Back
Capricor Therapeutics Stock Predictions
Buy
73
CAPR
Capricor Therapeutics
Last Price:
6.22
Seasonality Move:
8.34%
7 Day Trial
ALL ACCESS PASS
$
7
Capricor Therapeutics Stock Forecast
- Over the next 52 weeks, Capricor Therapeutics has on average historically fallen by 5.2% based on the past 19 years of stock performance.
- Capricor Therapeutics has fallen lower in 9 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 47.37%
-
Is Capricor Therapeutics Stock Undervalued?
The current Capricor Therapeutics [CAPR] share price is $6.20. The Score for CAPR is 73, which is 46% above its historic median score of 50, and infers lower risk than normal. - CAPR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
Will Capricor Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Capricor Therapeutics has on average historically fallen by 5.2% based on the past 19 years of stock performance.
Capricor Therapeutics Stock Rating
Buy
73
Capricor Therapeutics (CAPR)
is a Buy
Is Capricor Therapeutics overpriced?
- Capricor Therapeutics has fallen lower in 9 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 47.37%
Capricor Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
capricor.com
52-Week Data
52-Week High:
8.22
52-Week Low:
2.68
Prediction Charts
Market Cap:
197.23M
Price in USD:
6.20
Volume:
755.11K
Beta:
1.13
Technical Analysis
SMA50:
5.93
SMA100:
5.15
SMA200:
4.78
52-Wk Change:
42.69%
Stock Predictions
-
Is Capricor Therapeutics stock public?
Yes, Capricor Therapeutics is a publicly traded company. -
What is the Capricor Therapeutics stock quote today?
The Capricor Therapeutics stock price is 6.20 USD today. -
How to buy Capricor Therapeutics stock online?
You can buy Capricor Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-30 | 5.28 | 5.27 | 5.48 | 5.16 |
| May-1 | 5.28 | 5.31 | 5.44 | 5.24 |
| May-2 | 5.40 | 5.24 | 5.40 | 5.18 |
| May-3 | 5.28 | 5.47 | 5.78 | 5.28 |
| May-6 | 5.47 | 5.53 | 5.57 | 5.45 |
| May-7 | 5.58 | 5.46 | 5.68 | 5.41 |
| May-8 | 5.36 | 5.37 | 5.48 | 5.25 |
| May-9 | 5.36 | 5.40 | 5.49 | 5.33 |
| May-10 | 5.42 | 5.30 | 5.50 | 5.23 |
| May-13 | 5.34 | 5.44 | 5.44 | 5.26 |
| May-14 | 5.13 | 5.20 | 5.47 | 5.00 |
| May-15 | 5.21 | 5.33 | 5.47 | 5.21 |
| May-16 | 5.36 | 5.64 | 5.80 | 5.27 |
| May-17 | 5.79 | 6.20 | 6.53 | 5.79 |
Capricor Therapeutics Earnings
Capricor Therapeutics Earnings Report: Per Share Capricor Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Capricor Therapeutics Forecast Revenue Growth
Capricor Therapeutics Stock Analysis: Historical quarterly revenues per share for Capricor Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.03 per share, a decrease this year of $0.16 per share, and an increase next year of $0.74 per share.
* Capricor Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.